Risk factors for fluconazole-resistant candidemia.
Garnacho-Montero, José; Díaz-Martín, Ana; García-Cabrera, Emilio; Ruiz Pérez de Pipaón, Maite; Hernández-Caballero, Clara; Aznar-Martín, Javier; Cisneros, José M; Ortiz-Leyba, Carlos.
Antimicrob Agents Chemother
; 54(8): 3149-54, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-20498325
Prevalence and Fluconazole Susceptibility Profile of Candida spp. Clinical Isolates in a Brazilian Tertiary Hospital in Minas Gerais, Brazil.
The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study.
Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.
Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?
New clonal strain of Candida auris, Delhi, India.
Nosocomial candidiasis in Rio de Janeiro State: Distribution and fluconazole susceptibility profile.
Microbial profile and drug resistance of Candida strains isolated from the blood of children: an 11-year study.
Empirical treatment of candidemia in intensive care units: fluconazole or broad-spectrum antifungal agents?
Candida duobushaemulonii: an emerging rare pathogenic yeast isolated from recurrent vulvovaginal candidiasis in Brazil.
Association of fluconazole pharmacodynamics with mortality in patients with candidemia.